Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 7/2012

Open Access 01-10-2012 | Brief Report

Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report

Authors: Jennifer Sayanlar, Nilufer Guleyupoglu, Russell Portenoy, Sait Ashina

Published in: The Journal of Headache and Pain | Issue 7/2012

Login to get access

Abstract

Postherpetic neuralgia has been variably defined but is generally understood to be pain that persists for longer than a few months after an attack of herpes zoster. Pain persists for years in approximately 10 % of those afflicted with acute herpes zoster. The likelihood of postherpetic neuralgia increases with older age, severity of the zoster, trigeminal location, and other factors. Postherpetic neuralgia is a neuropathic pain and treatment usually involves sequential trials of topical and systemic drugs; a variety of other therapies may be considered in refractory cases. A new topical capsaicin 8 % patch has been approved for this indication based on the positive studies in patients with non-trigeminal postherpetic neuralgia. Experience with the use of the capsaicin 8 % patch for trigeminal distribution neuralgia is lacking. We report a case of trigeminal postherpetic neuralgia which was safely and effectively treated with capsaicin 8 % patch.
Literature
1.
Kost RG, Straus SE (1996) Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 335:32–42, 8637540, 10.1056/NEJM199607043350107, 1:CAS:528:DyaK28Xkslamsro%3DCrossRefPubMed
2.
Cunningham AL, Dworkin RH (2000) The management of post-herpetic neuralgia. BMJ 321:778–779, 11009498, 10.1136/bmj.321.7264.778, 1:STN:280:DC%2BD3M%2FhvFagsw%3D%3DPubMedCentralCrossRefPubMed
3.
Jung BF, Johnson RW, Griffin DR et al (2004) Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62:1545–1551, 15136679, 10.1212/01.WNL.0000123261.00004.29CrossRefPubMed
4.
Opstelten W, Mauritz JW, de Wit NJ et al (2002) Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 19:471–475, 12356697, 10.1093/fampra/19.5.471CrossRefPubMed
5.
Nagasako EM, Johnson RW, Griffin DR et al (2002) Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 46:834–839, 12063479, 10.1067/mjd.2002.120924CrossRefPubMed
6.
Brown GR (1976) Herpes zoster: correlation of age, sex, distribution, neuralgia, and associated disorders. South Med J 69:576–578, 1273613, 10.1097/00007611-197605000-00028, 1:STN:280:DyaE287pvFCgtg%3D%3DCrossRefPubMed
7.
Goh CL, Khoo L (1997) A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 36:667–672, 9352407, 10.1046/j.1365-4362.1997.00241.x, 1:STN:280:DyaK1c%2FhtlKrtg%3D%3DCrossRefPubMed
8.
Dubinsky RM, Kabbani H, El-Chami Z et al (2004) Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63:959–965, 15452284, 10.1212/01.WNL.0000140708.62856.72, 1:STN:280:DC%2BD2cvotlymsQ%3D%3DCrossRefPubMed
9.
Dworkin RH, Johnson RW, Breuer J et al (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44:S1–S26, 17143845, 10.1086/510206, 1:CAS:528:DC%2BD2sXmt12gsA%3D%3DCrossRefPubMed
10.
Hempenstall K, Nurmikko TJ, Johnson RW et al (2005) Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2:e164, 16013891, 10.1371/journal.pmed.0020164PubMedCentralCrossRefPubMed
11.
Edelsberg JS, Lord C, Oster G (2011) Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 45:1483–1490, 22085778, 10.1345/aph.1P777, 1:CAS:528:DC%2BC38XitVKjtb8%3DCrossRefPubMed
12.
Haythornthwaite JA, Benrud-Larson LM (2001) Psychological assessment and treatment of patients with neuropathic pain. Curr Pain Headache Rep 5:124–129, 11252146, 10.1007/s11916-001-0080-4, 1:STN:280:DC%2BD3MzisVWjug%3D%3DCrossRefPubMed
13.
Wu CL, Raja SN (2008) An update on the treatment of postherpetic neuralgia. J Pain 9:S19–S30, 18166462, 1:CAS:528:DC%2BD1cXhtlSnuw%3D%3DCrossRefPubMed
14.
Watson CP, Tyler KL, Bickers DR et al (1993) A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 15:510–526, 8364943, 1:STN:280:DyaK3szntlensw%3D%3DPubMed
15.
Backonja M, Wallace MS, Blonsky ER et al (2008) NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 7:1106–1112, 18977178, 10.1016/S1474-4422(08)70228-X, 1:CAS:528:DC%2BD1cXhsFCrsLvMCrossRefPubMed
16.
Irving GA, Backonja MM, Dunteman E et al (2011) A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med 12:99–109, 21087403, 10.1111/j.1526-4637.2010.01004.xCrossRefPubMed
17.
Backonja MM, Malan TP, Vanhove GF et al (2010) NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med 11:600–608, 20113411, 10.1111/j.1526-4637.2009.00793.xCrossRefPubMed
18.
Papoiu AD, Yosipovitch G (2010) Topical capsaicin. The fire of a ‘hot’ medicine is reignited. Expert Opin Pharmacother 11:1359–1371, 20446852, 10.1517/14656566.2010.481670, 1:CAS:528:DC%2BC3cXlslCisrw%3DCrossRefPubMed
19.
Anand P, Bley K (2011) Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 % patch. Br J Anaesth 107:490–502, 21852280, 10.1093/bja/aer260, 1:CAS:528:DC%2BC3MXhtFKiu77MPubMedCentralCrossRefPubMed
20.
Alawi K, Keeble J (2010) The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 125:181–195, 19896501, 10.1016/j.pharmthera.2009.10.005, 1:CAS:528:DC%2BC3cXitVKjsbg%3DCrossRefPubMed
21.
Polak JM, Bloom SR (1981) The peripheral substance P-ergic system. Peptides 2:133–148, 6178091, 10.1016/0196-9781(81)90024-3, 1:CAS:528:DyaL38XhsFGlsrs%3DCrossRefPubMed
22.
Kennedy WR, Vanhove GF, Lu SP et al (2010) A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 11:579–587, 20400377, 10.1016/j.jpain.2009.09.019, 1:CAS:528:DC%2BC3cXmslOntLk%3DCrossRefPubMed
23.
Malmberg AB, Mizisin AP, Calcutt NA et al (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111:360–367, 15363880, 10.1016/j.pain.2004.07.017, 1:CAS:528:DC%2BD2cXnsFSqsLw%3DCrossRefPubMed
24.
Holzer P (2008) The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 155:1145–1162, 18806809, 10.1038/bjp.2008.351, 1:CAS:528:DC%2BD1cXhsVKlt73NPubMedCentralCrossRefPubMed
Metadata
Title
Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report
Authors
Jennifer Sayanlar
Nilufer Guleyupoglu
Russell Portenoy
Sait Ashina
Publication date
01-10-2012
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 7/2012
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-012-0467-0

Other articles of this Issue 7/2012

The Journal of Headache and Pain 7/2012 Go to the issue

Original

Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women

Letter to the Editor

Reply to letter to editor

Tutorial

Migraine headache: a review of the molecular genetics of a common disorder

Original

Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples

Letter to the Editor

Vitamin C for attenuating postherpetic neuralgia pain: an emerging treatment alternative

Rapid Communication

Hemicrania continua in a headache clinic: referral source and diagnostic delay in a series of 22 patients